Ahead of his talk at the 7th Annual Allogeneic Cell Therapies Summit, Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and large-scale ...
Please provide your email address to receive an email when new articles are posted on . Allogeneic cell therapies help overcome challenges of autologous products, such as manufacturing complexity and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results